A detailed history of Xtx Topco LTD transactions in Geron Corp stock. As of the latest transaction made, Xtx Topco LTD holds 35,421 shares of GERN stock, worth $161,873. This represents 0.01% of its overall portfolio holdings.

Number of Shares
35,421
Previous 60,436 41.39%
Holding current value
$161,873
Previous $199,000 24.62%
% of portfolio
0.01%
Previous 0.03%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$3.1 - $5.09 $77,546 - $127,326
-25,015 Reduced 41.39%
35,421 $150,000
Q1 2024

May 13, 2024

SELL
$1.75 - $3.44 $338,380 - $665,158
-193,360 Reduced 76.19%
60,436 $199,000
Q4 2023

Feb 13, 2024

BUY
$1.74 - $2.31 $344,436 - $457,269
197,952 Added 354.47%
253,796 $535,000
Q3 2023

Nov 13, 2023

BUY
$2.11 - $3.28 $117,830 - $183,168
55,844 New
55,844 $118,000
Q1 2023

May 12, 2023

SELL
$2.14 - $3.4 $24,436 - $38,824
-11,419 Reduced 18.0%
52,016 $112,000
Q4 2022

Feb 14, 2023

BUY
$2.03 - $2.42 $54,028 - $64,408
26,615 Added 72.28%
63,435 $153,000
Q3 2022

Nov 14, 2022

BUY
$1.67 - $2.94 $1,982 - $3,489
1,187 Added 3.33%
36,820 $86,000
Q2 2022

Aug 15, 2022

SELL
$1.19 - $1.65 $23,590 - $32,709
-19,824 Reduced 35.75%
35,633 $55,000
Q1 2022

May 13, 2022

BUY
$0.99 - $1.6 $54,902 - $88,731
55,457 New
55,457 $75,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.73B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.